Frederick Derosier, DO

Frederick Derosier, DO, is Fortrea’s Vice President for Rare Diseases, Advanced Therapies, and Pediatrics and additionally serves as Therapeutic Strategy Lead for Cell and Gene Therapies. Dr. Derosier has 24 years of pharmaceutical/biotech experience and 10 years of clinical practice experience in Internal Medicine; he has been focused exclusively on medicines development in rare diseases for the past 15 years. He supports Fortrea clinical teams across the rare diseases and in CGT strategies. His Phase I – IV experience spans small molecules, combination products, biologics, and cell/gene/RNA therapeutics, and he has experience leading global clinical development programs covering clinical development strategy and planning, protocol development, and regulatory and patient advocacy group interactions.